Podcasts about obstructive

Obstructive sleep apnea affects a whopping 30 million Americans, yet millions remain undiagnosed or abandon CPAP therapy due to its discomfort and inconvenience. Recent innovations in oral appliance therapy, however, are opening up new possibilities for patients seeking safe, effective, and lasting solutions. With sleep apnea linked to virtually every chronic disease—from heart disease to diabetes—the stakes couldn't be higher.So, what if there were a way to actually remodel the airway and reduce dependence on CPAP altogether? Could a non-surgical, dental-based approach reshape the future of sleep apnea treatment?Welcome to I Don't Care. In the latest episode, host Dr. Kevin Stevenson speaks with R. Kirk Huntsman, Chairman and CEO of Vivos Therapeutics. Together, they explore how airway remodeling through oral appliances may offer patients an alternative to CPAP, why craniofacial development is so central to sleep disorders, and how innovations in treatment are changing lives across the country.In this episode, you'll learn:How Vivos Therapeutics' oral appliance technology works by repositioning and redeveloping the jaws to create wider, more functional airways.Why environmental, genetic, and lifestyle factors have led to narrower airways in modern populations—and how this contributes to the rise of sleep apnea.What patients can expect in terms of treatment timelines, insurance coverage, and long-term outcomes, including reducing or eliminating dependence on CPAP.R. Kirk Huntsman is a seasoned healthcare entrepreneur with over 35 years of experience founding and leading companies in dental practice management, medical devices, and healthcare services. He built and scaled Dental One, Inc. into a $70M business before its sale, and later co-led the merger that created DentalOne Partners, operating over 150 practices nationwide. Currently Chairman and CEO of Vivos Therapeutics, he focuses on strategic growth, capital acquisition, and innovative technologies to advance treatment for sleep and airway disorders.

Ischemia with No Obstructive Arteries (INOCA) in 2024    Guest: Claire Raphael, M.B.B.S., Ph.D. Host: Sharonne Hayes, M.D.   INOCA is a common condition. It is an acronym that stands for ischemia with non-obstructive coronary artery disease. We discuss when to consider a diagnosis of INOCA, how to diagnose it and how to treat patients.   Topics Discussed: What is INOCA? Who is at risk for INOCA? How do we manage INOCA?   Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode.   Podcast episode transcript found here.

Stephen Grootes speaks to Carol Paton, Editor-at-Large at Fin24, about South Africa’s obstructive stance at the WTO, which she calls embarrassing and clearly misguided. Stephen Grootes speaks to veteran broadcaster Neil Andrews about his remarkable journey from horse-racing commentary to becoming one of South Africa’s most beloved sports presenters, highlighting the passion, versatility, and humility that have defined his decades-long career. The Money Show is a podcast hosted by well-known journalist and radio presenter, Stephen Grootes. He explores the latest economic trends, business developments, investment opportunities, and personal finance strategies. Each episode features engaging conversations with top newsmakers, industry experts, financial advisors, entrepreneurs, and politicians, offering you thought-provoking insights to navigate the ever-changing financial landscape. Thank you for listening to a podcast from The Money Show Listen live Primedia+ weekdays from 18:00 and 20:00 (SA Time) to The Money Show with Stephen Grootes broadcast on 702 https://buff.ly/gk3y0Kj and CapeTalk https://buff.ly/NnFM3Nk For more from the show, go to https://buff.ly/7QpH0jY or find all the catch-up podcasts here https://buff.ly/PlhvUVe Subscribe to The Money Show Daily Newsletter and the Weekly Business Wrap here https://buff.ly/v5mfetc The Money Show is brought to you by Absa Follow us on social media 702 on Facebook: https://www.facebook.com/TalkRadio702 702 on TikTok: https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/CapeTalk 702 on YouTube: https://www.youtube.com/@radio702 CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/Radio702 CapeTalk on YouTube: https://www.youtube.com/@See omnystudio.com/listener for privacy information.

AUA2025: John Duckett Memorial Lecture: Obstructive Bladder Disease: Molecular Insights and Therapeutic Opportunities Presenter: Rosalyn M. Adam, PhD

Commentary by Dr.  Jian'an Wang.

Atypical sleep apnoea in women, often presenting as fatigue, insomnia or anxiety Why all pregnant women in their second trimester should be screened Loud snoring and hyperactivity in children are red flags for sleep apnoea Home sleep test access, Medicare criteria, and private options explained Supporting CPAP setup, troubleshooting and when to refer Host: Dr David Lim | Total Time: 41 mins Expert: Dr Alison Wimms, Director of Medical Affairs Register for our fortnightly FREE WEBCASTSEvery second Tuesday | 7:00pm-9:00pm AEST Click here to register for the next oneSee omnystudio.com/listener for privacy information.

This activity was supported by an educational grant from Bristol Myers Squibb. Please go to ⁠academiccme.com/HFPod and complete the evaluation to receive your CE/CME Credit. Credit is available through May 15, 2026.

Commentary by Dr. Jian'an Wang.

Primary and Secondary Outcomes of the Women's Ischemia Trial to Reduce Events in Non-Obstructive Coronary Artery Disease

Obstructive sleep apnea (OSA) is an increasingly common diagnosis. Yet most behavioral health providers are unaware that they can play a role in both the assessment and treatment of OSA in their patients. Today we're joined by an expert in the subfield of sleep psychology, Dr. Phil Gehrman. He shares basic information about what OSA is, how providers can effectively screen for it, and how they can facilitate treatment for this dangerous condition. Despite what you might have heard before, Dr. Gehrman posits that behavioral health providers can play “a huge potential role that really is untapped.” Dr. Phil Gehrman is Professor of Psychology in the Department of Psychiatry of the University of Pennsylvania School of Medicine. He directs the Sleep, Neurobiology and Psychopathology lab at Penn. He has an active research program exploring the mechanisms and treatment of sleep and circadian dysregulation in the context of mental health disorders. Dr. Gehrman's clinical specialization is on the delivery of cognitive behavioral and chronotherapeutic interventions for insomnia, circadian rhythm disorders, and other sleep disorders. The overarching goal of his work is to advance the understanding of the links between sleep and mental illness through translational research that spans biology to therapeutics.Resources mentioned in this episode: STOP Screening tool for Obstructive Sleep Apnea: https://deploymentpsych.org/content/insomnia-toolsMotivational Interviewing for CPAP Adherence: Rapelli G, Pietrabissa G, Manzoni GM, Bastoni I, Scarpina F, Tovaglieri I, Perger E, Garbarino S, Fanari P, Lombardi C and Castelnuovo G (2021) Improving CPAP Adherence in Adults With Obstructive Sleep Apnea Syndrome: A Scoping Review of Motivational Interventions. Front. Psychol. 12:705364. doi: 10.3389/fpsyg.2021.705364Motivational Interviewing resources: https://deploymentpsych.org/Clinical-Skills-ResourcesSystematic desensitization: https://www.veterantraining.va.gov/insomnia/docs/PAP_Desensitization.pdfPractical for Your Practice voice mail: speakpipe.com/cdpp4pPractical for Your Practice email: cdp-podcast-ggg@usuhs.edu Calls-to-action: Incorporate the STOP into your practiceBecome familiar with behavioral and motivational approaches listed aboveConnect with your local sleep medicine clinicReach out to us via Speakpipe with your questions and commentsSubscribe to the Practical for Your Practice PodcastSubscribe to The Center for Deployment Psychology Monthly Email at https://deploymentpsych.org/CDP-MED-Opt-In

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Investigating the Anrep Effect in Hypertrophic Obstructive Cardiomyopathy With Invasive Pressure-Volume Analysis.

Be alert to atypical symptoms, such as fatigue or reduced exercise tolerance, particularly in younger patients Serial Holter monitoring and attention to atrial ectopy burden can guide suspicion Wearables like the Apple Watch and Samsung Galaxy Watch are effective adjuncts for rhythm detection Early ablation may be appropriate, even in younger patients with a low CHA₂DS₂-VASc score, if they are symptomatic Collaboration between healthcare professionals and Electrophysiologists is essential to optimise patient outcomes The questions answered in this podcast are listed below.They were compiled by GPs and health professionals around Australia who attended Healthed’s face-to-face seminars. Atrial fibrillation – it's not an uncommon arrhythmia in Australia, is it? What are some of the environmental factors that have been identified as contributing to atrial fibrillation, apart from COVID? Why are we picking up more cases of atrial fibrillation? Are patients becoming more symptomatic? Obstructive sleep apnoea doesn't cause atrial fibrillation, but can it make it permanent? How can the pulmonary veins cause a cardiac arrhythmia? What are the indications for treating patients with ablation? How is it managed? What's the current thinking? How far should a healthcare professionals go in trying to detect atrial fibrillation in patients with unusual symptoms? Host: David Lim | Total Time: 32 mins Expert: Prof Rukshen Weerasooriya, Sub-specialist Cardiac Electrophysiologist Register for our fortnightly FREE WEBCASTSEvery second Tuesday | 7:00pm-9:00pm AEST Click here to register for the next oneSee omnystudio.com/listener for privacy information.

In this episode of PodMD, General and Interventional Cardiologist, Dr Kunal Nagar will be discussing the topic of unpacking non-obstructive coronary artery disease.

In this special episode on Obstructive Sleep Apnea our host, Dr. Neil Skolnik will discuss an overview of OSA. In Part 2 we will take a deep dive into diagnosis, Part 3 will discuss treatment options, and Part 4 will look at cases. This special episode is supported by an independent educational grant from Lilly. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Paul Doghramji, MD – Medical Director of Health Services at Ursinus College, Attending Family Physician at Collegeville Family Practice Selected references: Diagnosis and Management of Obstructive Sleep Apnea - A Review. JAMA. 2020;323(14):1389-1400 Obstructive sleep apnea and obesity: A review of epidemiology, pathophysiology and the effect of weight-loss treatments.  Sleep Medicine Reviews 2024;78:1-12

In this Healthed lecture, Prof Brendon Yee explains how GPs and specialists can work together to ensure effective management, balancing road safety with appropriate return-to-driving protocols after successful treatment.See omnystudio.com/listener for privacy information.

Story at-a-glance Obstructive sleep apnea (OSA) affects nearly a billion people worldwide. It causes breathing interruptions during sleep that prevent you from reaching restorative sleep stages Common symptoms include loud snoring, gasping/choking during sleep, morning headaches, daytime fatigue, difficulty concentrating and mood changes that are often mistaken for normal tiredness Risk factors for OSA include age, excess throat tissue, weak throat muscles, structural airway abnormalities and vitamin D deficiency, which affects sleep regulation and quality Untreated sleep apnea leads to serious health complications including cardiovascular disease, Type 2 diabetes, cognitive decline, weakened immune function and increased accident risk Treatment options include CPAP therapy, oral appliances, orofacial myofunctional therapy and lifestyle changes like optimizing breathing habits, maintaining healthy weight and adjusting sleep position

In today's VETgirl online veterinary continuing education podcast, Dr. Amy Kaplan, cVMA, DACVECC, MRCVS discusses a potential way to help smooth out surgical recovery in those tricky brachycephalic patients. Listen along to hear the benefits one study found in having owners present to help recover their canine companion following airway surgery, as supported in the veterinary journal article, "Owner-assisted Recovery and Early Discharge After Surgical Treatment in Dogs with Brachycephalic Obstructive Airway Syndrome."

Une première étape dans la lutte contre lʹostéoporose Les brèves du jour Des ateliers pour mieux vivre avec une bronchopneumopathie chronique obstructive Incroyable histoire de la géographie 2/2

Au lendemain d'une émission consacrée aux conseils et prises en charge pour cesser de fumer, nous parlons aujourd'hui d'une maladie chronique directement liée — dans une majorité de cas — à cette exposition au tabac. À l'occasion de la journée mondiale contre la BPCO (le 21 novembre), nous faisons un point sur cette maladie chronique inflammatoire des bronches. Quelles expositions ou habitudes du quotidien favorisent le risque de BPCO, cette maladie respiratoire chronique ?  Pr Bruno CRESTANI, chef de service de pneumologie à l'hôpital Bichat Claude-Bernard à Paris. Président de la Fondation du Souffle   (Rediffusion)Retrouvez l'émission dans son intégralité ici : La BPCO, bronchopneumopathie chronique obstructive 

This episode covers hypertrophic obstructive cardiomyopathy.Written notes can be found at https://zerotofinals.com/paediatrics/cardiology/hypertrophicobstructivecardiomyopathy/Questions can be found at https://members.zerotofinals.com/Books can be found at https://zerotofinals.com/books/The audio in the episode was expertly edited by Harry Watchman.

Sleep apnea is a sleep disorder characterized by repeated interruptions in breathing during sleep. Obstructive sleep apnea (OSA) is the most common type of sleep apnea, characterized by repeated episodes of partial or complete blockage of the airway during sleep. These blockages occur when the muscles at the back of the throat relax excessively, causing the airway to narrow or close, and momentarily stopping breathing. This condition contrasts with central sleep apnea, where the brain fails to send proper signals to the muscles that control breathing. When the brain is deprived of oxygen during sleep, OSA can lead to a number of serious conditions affecting not only quality of life, but brain health and function. It is important to seek medical attention.Omid B. Mehdizadeh, MD, is an otolaryngology-head & neck (ENT) surgeon with particular expertise in voice, swallowing and airway conditions at Pacific Neuroscience Institute (PNI). A Los Angeles native, his career has spanned treating world-class opera and Broadway singers to surgical mission trips serving underprivileged and indigenous populations of Central America. Outside PNI, he has focused his time on educating medical and undergraduate students and providing medical care to disenfranchised populations through community clinics.

$5 Q-BANK: https://patreon.com/highyieldfamilymedicine Intro 0:30, Hypertension classifications 1:45, Lifestyle modifications 3:00, Thiazide diuretics 4:16, ACE Inhibitors and ARBs 5:59 Calcium channel blockers 8:15, Beta blockers 9:36, Mineralocorticoid receptor antagonists 10:49, Goal-directed medical therapy 12:49, Resistent hypertension 15:37, Other antihypertensives 16:38, Hypertensive emergency 20:33, Hypertension in pregnancy 23:00, Primary hyperaldosteronism 24:38, Renal artery stenosis 26:24, Cushing syndrome 27:22 Pheochromocytoma 28:53, Obstructive sleep apnea 30:26, Coarctation of the aorta 31:30, Practice questions 32:30

Au lendemain d'une émission consacrée aux conseils et prises en charge pour cesser de fumer, nous parlons aujourd'hui d'une maladie chronique directement liée — dans une majorité de cas — à cette exposition au tabac. À l'occasion de la journée mondiale contre la BPCO (le 21 novembre), nous faisons un point sur cette maladie chronique inflammatoire des bronches. Quelles expositions ou habitudes du quotidien favorisent le risque de BPCO, cette maladie respiratoire chronique ?  Pr Bruno CRESTANI, chef de service de pneumologie à l'hôpital Bichat Claude-Bernard à Paris. Président de la Fondation du Souffle    Retrouvez l'émission dans son intégralité iciLa BPCO, bronchopneumopathie chronique obstructive 

Au lendemain d'une émission consacrée aux conseils et prises en charge pour cesser de fumer, nous parlons aujourd'hui d'une maladie chronique directement liée — dans une majorité de cas — à cette exposition au tabac. À l'occasion de la journée mondiale contre la BPCO (le 21 novembre), nous faisons un point sur cette maladie chronique inflammatoire des bronches. La bronchopneumopathie chronique obstructive (BPCO) est causée, dans environ 80% des cas, par la consommation de tabac, mais aussi par l'exposition à la biomasse, c'est-à-dire l'inhalation de fumées de combustion intérieure principalement, dans les Pays en Voie de Développement. Quels sont les symptômes de la BPCO ? Quelles prises en charge existent, pour les patients ?    Pr Bruno CRESTANI, chef de service de pneumologie à l'hôpital Bichat Claude-Bernard à Paris. Président de la Fondation du Souffle   Pr Alexandre Boko KOUASSI, pneumologue et responsable de l'unité d'aide au sevrage tabagique au CHU de Cocody en Côte d'Ivoire   Christiane Poculu, patiente atteinte de BPCO, sous oxygénothérapie. Patiente experte diplômée de la faculté de médecine de l'université de Marseille. Vice-présidente de l'association « Santé respiratoire France ». Vice-présidente de l'Alliance contre le tabac      Programmation musicale :► Seckou Keita – Bodula► Liniker – Negona dos olhos terriveis

Au lendemain d'une émission consacrée aux conseils et prises en charge pour cesser de fumer, nous parlons aujourd'hui d'une maladie chronique directement liée — dans une majorité de cas — à cette exposition au tabac. À l'occasion de la journée mondiale contre la BPCO (le 21 novembre), nous faisons un point sur cette maladie chronique inflammatoire des bronches. La bronchopneumopathie chronique obstructive (BPCO) est causée, dans environ 80% des cas, par la consommation de tabac, mais aussi par l'exposition à la biomasse, c'est-à-dire l'inhalation de fumées de combustion intérieure principalement, dans les Pays en Voie de Développement. Quels sont les symptômes de la BPCO ? Quelles prises en charge existent, pour les patients ?    Pr Bruno CRESTANI, chef de service de pneumologie à l'hôpital Bichat Claude-Bernard à Paris. Président de la Fondation du Souffle   Pr Alexandre Boko KOUASSI, pneumologue et responsable de l'unité d'aide au sevrage tabagique au CHU de Cocody en Côte d'Ivoire   Christiane Poculu, patiente atteinte de BPCO, sous oxygénothérapie. Patiente experte diplômée de la faculté de médecine de l'université de Marseille. Vice-présidente de l'association « Santé respiratoire France ». Vice-présidente de l'Alliance contre le tabac      Programmation musicale :► Seckou Keita – Bodula► Liniker – Negona dos olhos terriveis

Millions of people struggle with sleep, but letting a real condition go undiagnosed could be fatal. Obstructive sleep apnea occurs when the airway is blocked during sleep and can cause major issues, including your alertness during the day and mental health. Our experts discuss which treatment options may be right for you. Learn More: https://radiohealthjournal.org/i-accidentally-fell-asleep-at-the-wheel-the-dangers-of-sleep-apnea Learn more about your ad choices. Visit megaphone.fm/adchoices

MINOCA: Myocardial Infarction with Non-Obstructive Coronary Arteries   Guest: Claire E. Raphael, M.B.B.S., Ph.D. Host: Sharonne Hayes, M.D.   MINOCA is a myocardial infarction with no obstructive coronary artery disease.  This podcast will discuss the underlying causes of MINOCA, how to and who to investigate and discuss contemporary management strategies.   Topics Discussed: What is MINOCA? What testing should I consider in patients with MINOCA How are these patients treated?   Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV and @MayoCVservices. LinkedIn: Mayo Clinic Cardiovascular Services Cardiovascular Education App: The Mayo Clinic Cardiovascular CME App is an innovative educational platform that features cardiology-focused continuing medical education wherever and whenever you need it. Use this app to access other free content and browse upcoming courses. Download it for free in Apple or Google stores today! No CME credit offered for this episode. Podcast episode transcript found here.

Charlie Andrews talks to Dr Anthony (Tony) Wisken, Consultant Paediatric Gastroenterologist in Bristol.The Ingest podcast is hosted by Dr Charlie Andrews a GPwER in gastroenterology based near Bath. Charlie works as a GP partner at Somer Valley Medical Group, trained as an endoscopist and leads the national GPwER in gastroenterology training programme, launched in 2023 in the southwest of England. Charlie is a committee member of the PCSG (Primary Care Society of Gastroenterology). For more information visit pcsg.org.uk Chapters (00:00:05) - INGEST(00:01:02) - Chronic abdominal pain in children(00:07:47) - Pediatric gastroenterology, pain in the tummy(00:13:13) - Reflux in children, 6 years and older(00:15:26) - Headache and abdominal pain in children, age 6(00:21:34) - Idiopathic bowel syndrome in children(00:24:51) - Tummy pain 11, constipation(00:31:08) - Mesenteric adenitis 20, Cancer(00:35:06) - Functional GI disorders, the role of ultrasound(00:38:57) - Obstructive bowel disease in teenagers(00:45:41) - Gallstones in children, anaesthesia and surgery(00:47:01) - Celiac disease, tests and how to manage it(00:49:40) - Top 3 Take Homes for kids(00:51:51) - H. Pylori in children's tummy pain(00:55:37) - 3 take home points from the abdominal pain episode

Obstructive sleep apnea, commonly referred to as OSA, affects 25% of adults yet 80% of cases go undiagnosed. And we know that sleep-related breathing disorders can cause havoc on a patient's oral and systemic health. And with so many patients having OSA, dentists have an amazing opportunity to treat these patients that are already patients of record. In this episode, we'll hear from two experts on the best way to start the journey of dental sleep medicine, helping patients on their path to good oral and systemic health while boosting revenue for the practice.

In this episode, Dr. Valentin Fuster delves into the latest research on hypertrophic cardiomyopathy, highlighting the significant health status improvements achieved with the new cardiac myosin inhibitor, Aficamten, compared to placebo. The findings from the Sequoia HCM study reveal that Aficamten markedly enhances patients' quality of life and alleviates symptoms like chest pain and shortness of breath, paving the way for more effective treatments in this challenging condition.

In this episode, Dr. Valentin Fuster highlights the Forest HCM study, which focuses on the withdrawal of standard care medications in patients with obstructive hypertrophic cardiomyopathy receiving afficantin. The study shows promising results: nearly half of the patients who attempted to reduce or stop their medications did so successfully, with significant improvements in functional class and symptoms. While the findings suggest that afficantin may allow for the reduction of traditional therapies, caution is advised, as not all patients may benefit equally.

In this episode, Dr. Valentin Fuster introduces a dedicated focus on hypertrophic cardiomyopathy, featuring a pivotal study by Dr. Martin Maron and Dr. lacopo Olivotto on the impact of aficamptin. This pre-specified sub-analysis from the SEQUOIA HCM trial aims to comprehensively evaluate the drug's effects on various aspects of disease burden, enhancing our understanding of its clinical efficacy.

In this episode, Dr. Valentin Fuster delves into a groundbreaking study on the effects of the cardiac myosin inhibitor, Aficamten, on patients with obstructive hypertrophic cardiomyopathy. The findings reveal significant improvements in echocardiographic measures of cardiac function, despite a mild and reversible decrease in left ventricular ejection fraction, highlighting the need for long-term safety evaluations of this promising treatment.

In this episode, Dr. Valentin Fuster explores groundbreaking research on hypertrophic cardiomyopathy, focusing on the effects of the drug aficamten on cardiac structure and function. Highlighting significant findings from the Sequoia HCM trial, the discussion underscores the potential of aficamten to induce favorable cardiac remodeling and improve patient outcomes, signaling a transformative era in the management of this condition.

In this episode, Dr. Martin Stentebjerg Skøtt (DK) presents findings from a recently published systematic review on the topic of "Endoscopic balloon dilatation and incision for treating primary obstructive megaureter in children".Historically, ureteral re-implantation has been the gold standard for addressing primary obstructive megaureter (POM) in children, but its challenges, particularly in infants, have spurred interest in less invasive methods. Dr. Skott discusses the effectiveness, safety, and benefits of endoscopic management as an alternative to the traditional surgical approach.Dr. Skøtt also discussses potential complications, the need for long-term follow-up, and the importance of future research to refine treatment protocols for better patient outcomes.Join us for this insightful conversation as Dr. Martin Skott sheds light on cutting-edge approaches to managing primary obstructive megaureter in children.  Tune in and stay informed!

Join me for a summary looking into the increasingly popular topic of paediatric obstructive sleep apnoea, a review of orthodontic treatments available, and how effective they are in this growing field of both medicine and dentistry. This episode is a summary of Alberto Capriglio's lecture from the AAO and Carlos Flores Mir's lecture at the IOF earlier this year.     OSA - Defined upper airway dysfunction causing complete or partial airway obstruction during sleep   Sleep = Slow wave sleep – constructive phase of sleep (recuperation of the mind) ·      Growth hormones secreted ·      Glial cells within brain restored ·      Cortical synapses increase in number – Moberget 2019   Outcomes to paediatric patients of SDB: (AASM) ·      delays in development,  Poor academic performance, Aggressive behaviour, attention- deficit/hyperactivity disorder, , emotional problems in adolescence   First line medical treatment – adenotonsillectomy  ·      40% residual  OSA       Effect palatal expansion 1.        Roof the mouth = base of the nose - Increase in nasal airway volume - Reduction in OSA, if obstruction in naso-pharynx, 2.        Short term reduction in OSA (not cure AASM) a.        20% improvement in AHI, 85% of cases Villa 2015 b.        15% got worse by 20% c.        57.5% residual AHI greater than 1 - not resolution 3.        Caprioglio 2019 long term AHI return to initial scores, from 7 to 5 long term 4.        Change in metabolism when combined with Vit D3 a.        Vit D3 with RME increases reduction in AHI, sustained long term, Caprioglio 2019 AHI 61.9% Vs 35.5% long term     Expansion other outcomes -  school performance  Bariani 2024 ·      AJODO – RME improves academic performance – o   BEHAVOUR 1 of 8 parameters improved only for academic performance  - change small 0.68 o   COGNITIVE 1 in 8 improve       Mandibular advancement Move mandible forwards and open space behind the tongue – oropharynx ·      Anatomical – increase size of oropharangeal airway ·      YAnyAn 2019 mandibular advancement for pOSA systematic review:  1.75 AHI reduction (CI) −2.07, −1.44) – modest change ·      However long term use required of the paediatric patient     Orofacial features in children with obstructive sleep apnea.  Fagundes Flores-Mir 2022 o   No craniofacial features specific to pOSA – ANB, o   However medical diagnosis through polysomnography may under-estimate incidence, o   Broader diagnosis such as snoring, may over-estimate OSA   AADSM 2024 – consensus statement ·      Expansion o   Prevention: No consensus o   Management: No consensus o   Cure: Insufficient ·      Mandibular advancement o   Prevention, management, cure – unclear   More about OSA? To hear more about OSA, please check out the last interview on orthodontics in interview with Sanjivan Kandasamy, where we had a deep dive into OSA and where we are in our understanding today from the research Interview with Sanjivan Kandasamy on OSA                          

This week I'm talking to Dr Jane Ladlow. Jane is a veterinary surgeon who is widely known as an expert on BOAS, or brachycephalic obstructive airway syndrome. BOAS is the umbrella disorder that covers a variety of different airflow obstructions in different flat-faced breeds such as the pug, French bulldog, and English bulldog. Jane developed the Respiratory Function Grading Scheme, a straightforward clinical exam which allows grading of a BOAS-effected dog. Jane works with the Kennel Club in the UK to promote this scheme, which is also being rolled out in other countries including the US. I was really pleased to get to talk to Jane about BOAS, her grading scheme, and what this means for breeding healthy brachycephalic dogs.

Key takeaways from the IBS Part 1 episode of the PCSG Ingest podcast:Diagnosis of IBSThe episode is focused on making a diagnosis of Irritable Bowel Syndrome (IBS)and features Dr. Anton Emmanuel, a consultant gastroenterologist and Professor of neuro-gastroenterology at University College Hospital London.Importance for Primary CareIBS is a common condition that primary care clinicians need to have a structured approach to diagnosing.Topics CoveredCauses of IBS Different subtypes of IBS Challenges in making a positive diagnosisClinical PearlsDr. Emmanuel shares several insights:Key questions to include in the patient history How to describe the condition to patients Practical tips for enhancing IBS diagnosis in primary careDiagnostic ApproachThe episode emphasises the importance of:Taking a structured approach to diagnosis Understanding the various presentations of IBS Recognizing the challenges in making a definitive diagnosisPatient CommunicationGuidance is provided on:Explaining IBS to patients effectively Addressing patient concerns and misconceptionsAdditional ResourcesThe episode mentions useful guidance from the British Society of Gastroenterology, which listeners were encouraged to reference for more detailed information. Part 2 focusing on the management of IBS to be released soon.bsg.org.uk/clinical-resource/british-society-of-gastroenterology-guidelinesThe Ingest podcast is hosted by Dr Charlie Andrews a GPwER in gastroenterology based near Bath. Charlie works as a GP partner at Somer Valley Medical Group, trained as an endoscopist and leads the national GPwER in gastroenterology training programme, launched in 2023 in the southwest of England. Charlie is a committee member of the PCSG (Primary Care Society of Gastroenterology). For more information visit pcsg.org.uk Chapters (00:00:00) - Ingest(00:01:33) - Intense bowel dysrhythmia (IBs)(00:04:02) - How common is ibs?(00:06:17) - Obstructive bowel syndrome(00:10:06) - IBS: Classification and treatment tips(00:13:39) - Determining the diagnosis of IBS(00:14:44) - IBS(00:19:22) - IBS 12, Missing other comorbidities(00:22:21) - What to ask about IBS?(00:25:25) - IBS and secondary care,(00:29:33) - Confirmations about inflammatory bowel disease (IBs)(00:33:37) - Talking to the patient about ibs(00:35:09) - IBS, the diagnosis and treatment(00:38:11) - In the Know: Irritable bowel syndrome(00:40:22) - Irritable Bowel Syndrome(00:41:15) - The Primary Care Society for Gastroenterology Podcast

Obstructive sleep apnea in adults (1:40), e-cigarettes (5:30), breastfeeding support for healthy mothers and infants (7:40), hematologic emergencies (10:20), midodrine for recurrent vasovagal syncope (15:30), and cranberry products for preventing urinary tract infections (17:20).

PetAbility Podcast hosts, Cathy and Chris, once again lend their experiences and expertise to the show - this time discussing Brachycephalic Obstructive Airway Syndrome.Who gets it?What is it?Why should we care?With the popularity of Frenchies and other smoosh-faced dogs exponentially increasing  world-wide, caretakers of these endearing breeds need to be equipped to address some commonly concurrent medical issues. For example, their unique anatomical features negatively impact their ability to not only breathe, but also regulate their body temperature. This can lead to chronic respiratory distress, heat intolerance, and even death. However, there are surgical options as well as environmental changes, both at home and in physical rehab, that can improve these little  nuggets' quality of life. Educate yourself to potentially save a life!Support the Show.DisclaimerFollow us on Facebook, Instagram, TikTok, and YouTube.Check out VitalVet.org for all PetAbility Podcast episodes related to rehabilitation as well as a plethora of other resources and product information.MedcoVet (show sponsor) - the next generation in laser therapy by putting healing in the hands of the pet owner! By using the Promo Code PETPOD22, when placing your first order with any of our affiliate partners, you will receive 10% off and PetAbility receives 10% . Dr. Buzby's Toe Grips – dog nail grips to keep your dog from slipping! Extra love – use this link and the entire 20% goes to support our show! HedzUpPets Watercollars – save your dog from drowning with this unique lightweight collar when around any body of water!...

Brachycephalic obstructive airway syndrome (BOAS) is a chronic, lifelong and debilitating disease that adversely affects the quality of life of many popular dog breeds, such as French and English bulldogs, pugs and Boston terriers. Tune in to this VetFolio Voice podcast episode to learn about the anatomy of brachycephalic dogs and how it contributes to airway obstruction. Dr. Cassi and Dr. Fox-Alvarez delve into the indications for surgery and what types of surgical procedures are performed to help correct airway obstruction. They discuss comorbidities associated with BOAS as well as expectations for recovery from surgery and the long-term prognosis for these patients.

Christopher J. Allen, MD (SleepDrChris) is a board certified Sleep Medicine Doctor for kids and adults. He received his sleep medicine training at the University of Michigan (Go BLUE

CardioNerds Dr. Josh Saef and Dr. Tommy Das join Dr. Omkar Betageri, Dr. Andrew Geissler, Dr. Philip Lacombe, and Dr. Cashel O'Brien from the Maine Medical Center in Portland, Maine to enjoy an afternoon by the famous Portland headlight. They discuss a case of a patient who presents with obstructive cardiogenic shock. Dr. Bram Geller and Dr. Jon Donnelly provide the Expert CardioNerd Perspectives & Review segment for this episode. Dr. Maxwell Afari, the Maine Medical Center cardiology fellowship program director highlights the fellowship program. Audio editing by CardioNerds Academy Intern, student doctor Tina Reddy. This is the case of a 42 year-old woman born with complicated Tetralogy of Fallot repair culminating in a 29mm Edwards Sapiens (ES) S3 valve placement within a pulmonary homograft for graft failure who was admitted to the cardiac ICU for progressive cardiogenic shock requiring vasopressors and inotropic support. Initial workup showed lactic acidosis, acute kidney injury, elevated NT-proBNP, and negative blood cultures. TTE showed at least moderate biventricular systolic dysfunction. She was placed on furosemide infusion, blood cultures were drawn and empiric antibiotics initiated. Right heart catheterization demonstrated elevated right sided filling pressures, blunted PA pressures with low PCWP, low cardiac index, and low pulmonary artery pulsatility index. Intracardiac echocardiography (ICE) showed a large mass within the ES valve apparatus causing restrictive valve motion with a low gradient across the pulmonic valve in the setting of poor RV function. Angiography revealed a large filling defect and balloon valvuloplasty was performed with immediate hemodynamic improvement. Blood cultures remained negative, she was gradually weaned off of inotropic and vasopressor support, and discharged. Despite empiric treatment for culture negative endocarditis and ongoing anticoagulation, she was readmitted for recurrent shock one month later at which time the pulmonic mass was revisualized on ICE. A valve-in-valve transcatheter pulmonary valve (29mm ES S3) was placed to compress what was likely pannus, with an excellent hemodynamic result and no visible mass on ICE. US Cardiology Review is now the official journal of CardioNerds! Submit your manuscript here. CardioNerds Case Reports PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Case Media Pearls - Obstructive Cardiogenic ShocK Tetralogy of Fallot is the most common cyanotic defect and can lead to long term complications after surgical repair including chronic pulmonary insufficiency, RV dysfunction, residual RVOT obstruction and branch pulmonary artery stenoses. Chronic RV failure may be more indicative of a structural defect and therefore require interventional or surgical management. Valve thrombosis, infective endocarditis and obstructive pannus formation should be considered in the differential of a patient with obstructive shock with a prosthetic valve. Bioprosthetic pulmonic valve obstruction may be effectively managed with balloon valvuloplasty in patients who present in acute extremis but TCPV will likely provide a more lasting result. While valvular gradients are typically assessed via echocardiography, invasive hemodynamics can serve as a critical adjunctive tool in its characterization. Show Notes - Obstructive Cardiogenic ShocK Notes were drafted by Drs. Omkar Betageri, Philip Lacombe, Cashel O'Brien, and Andrew Geissler. What are the common therapies and management for Tetralogy of Fallot? Tetralogy of Fallot is the most common cyanotic defect in children beyond the age of one year Anatomic Abnormalities: Anterior and Superior deviation of the conal septum creating a SubAo VSD and encroachment on the RVOT.

Obstructive shock may be the least common type of shock, but it's no less critical. As part of Nurse PodCrawl 2024, Bryan Boling and Brandon Oto from the Critical Care Scenarios podcast join host Sarah Lorenzini in this episode to talk about the critical care management of obstructive shock. Together, they walk nurses through a patient scenario, detailing the diagnostic process of obstructive shock due to pulmonary embolism.Sarah, Bryan and Brandon review the three main causes of obstructive shock: pulmonary embolism, tension pneumothorax, and cardiac tamponade. They also discuss the importance of clinical assessments and diagnostic tools like ultrasound to distinguish between each cause, as well as considerations for treatment.This episode is the perfect resource for nurses who want to deepen their understanding of obstructive shock. Tune in now to hear insights from three experienced pros!Topics discussed in this episode:Patient assessment and key diagnostic toolsDiagnosing obstructive shock due to pulmonary embolismTreating obstructive shock due to pulmonary embolismTreatment implications for major causes of obstructive shockDiagnosis and treatment of tension pneumothoraxTreatment strategies for cardiac tamponadeKey takeaways on obstructive shock managementCheck out the rest of Nurse PodCrawl 2024 episodes around cardiogenic, hypovolemic, and distributive shock!Critical Care Scenarios: https://podcasts.apple.com/us/podcast/critical-care-scenarios/id1491559787How Not to Kill Your Patient: https://podcasts.apple.com/us/podcast/how-not-to-kill-your-patient/id1612099061Nurse Dose Podcast: https://podcasts.apple.com/us/podcast/nurse-dose-podcast/id1486427611The Q Word Podcast: https://podcasts.apple.com/us/podcast/the-q-word-podcast/id1407523803Straight A Nursing: https://podcasts.apple.com/us/podcast/straight-a-nursing-study-for-nursing-school-exams-nclex/id1210975738Up My Nursing Game: https://podcasts.apple.com/us/podcast/up-my-nursing-game/id1527032817Mentioned in this episode:Nurse's Week 2024 SpecialHAPPY NURSE'S WEEK! You can use code: NURSESWEEK2024 When you check out to get 50% off your first month of Rapid Response AcademyRapid Response and Rescue Intro CourseCONNECT

Our collaboration with Sarah Lorenzini of the Rapid Response RN podcast, discussing a case and general principles for diagnosing and managing obstructive shock. Check out the other episodes on shock in the Nurses' Podcrawl 2024! Find us on Patreon here! Buy your merch here!

In today's episode we take you through our approach to a disease with a wide array of clinical presentations and evolving treatment landscape - hypertrophic obstructive cardiomyopathy. Written by: Dr. Kate Haichin (Internal Medicine Resident) Reviewed by: Dr. Michael Chetrit (Cardiologist) & Dr. John Angelopoulos (General Internist) Support the show

CardioNerds Dr. Rick Ferraro (cardiology fellow at Johns Hopkins Hospital) and Dr. Eunice Dugan (cardiology fellow at the Cleveland Clinic) join episode lead Dr. Tiffany Brazile (cardiology fellow at the University of Texas Southwestern Medical Center and postdoctoral fellow at the Institute for Exercise and Environmental Medicine) to discuss the impact of obesity on cardiovascular disease risk, differential risk in specific populations, and effective strategies for counseling patients. They are joined by expert Dr. Jaime Almandoz, Medical Director of the Weight Wellness Program and an Associate Professor of Medicine at the University of Texas Southwestern Medical Center. Audio editing was performed by CardioNerds Academy Intern, student Dr. Tina Reddy. This episode was produced in collaboration with the American Society of Preventive Cardiology (ASPC) with independent medical education grant support from Novo Nordisk. See below for continuing medical education credit. Claim CME for this episode HERE. CardioNerds Prevention PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! Pearls and Quotes - Obesity & Cardiovascular Disease Risk The durability of metabolically healthy obesity (i.e., normal A1c, lipids, LFTs, BMP, normotensive) is limited. Within 5 years, a third of adults with “metabolically healthy” obesity will develop a cardiometabolic complication. The biomechanical and psychosocial complications of obesity are just as important as the cardiometabolic complications. Biomechanical and psychosocial complications, including obstructive sleep apnea, joint pain, and mood disorders also influence cardiovascular disease risk. Weight loss is not always the patient's goal. Meet patients where they are and understand their challenges, concerns, and long-term goals with respect to their cardiovascular health and obesity. This information provides an opportunity to frame the conversation in a supportive and engaging way that allows for patient education. Body mass index (BMI) is a screening tool for obesity, but is not sufficient for providing individualized care. Obesity management methods that result in rapid weight loss may not be appropriate for all patients. These methods, such as bariatric surgery and GLP1-receptor agonists, require regular monitoring, follow-up, and multidisciplinary care (e.g., nutritionist, exercise physiologist, endocrinologist, cardiologist, psychologist, etc.). Show notes - Obesity & Cardiovascular Disease Risk Is it possible to be healthy at any size? Whether an individual can be healthy at any size depends on the definition of health and its durability.Approximately 10-15% of adults with obesity are metabolically healthy.The risk for developing cardiometabolic disease is higher in obese versus non-obese adults. One in three adults with metabolically healthy obesity will develop cardiometabolic complications (i.e., insulin resistance/diabetes, hyperlipidemia, hypertension) within five years. Thus, metabolically healthy obesity may represent a transient phenotype with adverse long-term consequences. Consider non-metabolic health consequences of obesity that also influence cardiovascular disease risk. Obstructive sleep apnea, joint pain leading to decreased physical activity, and mood disorders are key considerations here and encompass the biomechanical and psychosocial consequences of obesity. Does large, rapid weight loss result in poorer long-term weight loss than slower, gradual weight loss? When approaches to weight loss are not sustainable, such as extremely low-calorie diets or extreme fitness regimens, the results and associated health benefits are less likely to be durable. Rapid, large-magnitude weight loss is appropriate for some adults with obesity and can be achieved throug...

Visit www.drstevenlin.com for this episode and moreSleep apnea is snoring and associated pausing of breathing during sleep. Obstructive sleep apnea (OSA) is diagnosed when breathing stops for a certain amount of time and oxygen levels drop.Symptoms include daytime tiredness, dry mouth, low energy, and insomnia.  Today nearly 1 billion people suffer from sleep apnea.Long term complications of sleep apnea include heart disease, metabolic dysfunction, and Alzheimer's disease.Solutions for snoring are difficult as breathing is a learned behavior, however structural jaw problems like a narrow dental arch can increase risk.A narrow palate or upper jaw is a risk factor for snoring and sleep apnea.My guest this week is Professpr Dave Singh, founder of Vivos. Prof Singh has been researched adult palate expansion to shift craniofacial epigenetics for positive impact on the airway and sleep apnea. Vivos has a range of devices FDA cleared to help treat sleep apnea and OSA.For more information on Dr. Singh and VIVOS, visit https://vivos.com/

This week we delve into cardiovascular surgery when we review a recent report from the Congenital Surgeons' Society on the outcomes of the hybrid approach of pulmonary artery bands for treatment of infants with critical left heart obstructive disease. What risk factors are associated with worse outcomes? Does this approach confer an advantage in comparison to the traditional 'stage I/Norwood' approach to this problem? Does the presence of multiple risk factors worsen outcomes and if so, to what degree? How does the heterogeneity of indications for this approach to obstructive left heart lesions stymie efforts to study this intervention? DOI: 10.1016/j.jacc.2023.07.020Editorial Comment :DOI: 10.1016/j.jacc.2023.08.023

Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I'm a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients. Obstructive sleep apnea (OSA) is a common condition where the muscles in the throat relax during sleep, causing partial or complete airway blockage. Risk factors include obesity, age, family history, and being male. Symptoms include loud snoring, gasping, and excessive daytime sleepiness. Left untreated, OSA can increase risks of high blood pressure, heart disease, diabetes, and vehicle accidents. Diagnosis involves an overnight sleep test to measure breathing disruptions. Weight loss and lifestyle changes can help mild cases. Treatment often involves using a CPAP machine, which blows air to keep the airway open during sleep and reduces daytime sleepiness by 70%. This episode highlights how undiagnosed OSA in truck drivers increases safety risks on the road.